He is a Fellow of the Neurocritical Care Society, the American Heart Association, the American College of Emergency Physicians, and the American Academy of Emergency Medicine.
Dr. Goldstein manages clinical research program integrating neurology, hematology, neurocritical care, and emergency medicine. He has been continually NIH funded since 2009, and receives funding from foundations and industry, and consults for multiple pharmaceutical and biotech companies on drug development and clinical trial management.
He currently serves as the hub PI for the New England SIREN group, an NIH funded national network that performs large phase III clinical trials in emergency and critical care (published in journals such as NEJM and Lancet).